Novotech Archives | Page 3 of 4

Home / Posts tagged Novotech (Page 3)

Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data

BOSTON, Oct. 12, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announces significant senior executive hires to further expand services for Novotech’s global biotech clients. Rick Farris, a seasoned professional in the clinical research and life sciences industry, has taken on the role of Managing Director for North [...]

Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Korea Summit

SEOUL, Korea, Oct. 12, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today that Dr. Yooni Kim, Vice President of Clinical Services at Novotech, served as a keynote speaker at the Veeva Korea Summit this week in Seoul, Korea. Novotech has been utilizing Veeva’s technology for over a decade [...]

Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award

BOSTON, Oct. 10, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, has been selected as the CRO Company of the Year 2023 by growth advisory and opportunity analytics firm Frost & Sullivan. Novotech has been a recipient of the Frost & Sullivan Best Practices awards since 2006. Novotech’s Vice President, [...]

Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services

Novotech Brand Video from Novotech on Vimeo. BOSTON, Oct. 03, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today the appointment of Dr. Judith Ng-Cashin as Chief Medical Officer (CMO). Learn more about Dr. Judith Ng-Cashin here Dr. Ng-Cashin, who brings 20 years of international pharmaceutical, biotech, [...]

Novotech Awarded Cell & Gene Therapy CRO Excellence 2023

SINGAPORE, Sept. 19, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at the Asia Pacific Cell & Gene Therapy Excellence Awards. Novotech’s Vice President, Clinical Services Dr. Yooni Kim accepted the award at [...]

Clinical Trials in China: Unlocking the Potential of Advanced Therapies Presented by Novotech and Endpoints News

BOSTON, Sept. 11, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in China: Unlocking the Potential of Advanced Therapies. Novotech is collaborating with Endpoints News to jointly host this webinar. The webinar will examine how China’s focus on cutting-edge innovations and [...]

Novotech Releases Comprehensive Global Landscape Report on Gallbladder Cancer Clinical Trials

BOSTON, Sept. 7 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report –“Gallbladder Cancer: Global Clinical Trials Landscape Report”. According to the report, biopharma companies have initiated approximately 250 ongoing clinical trials in gallbladder cancer (GBC) since 2016, with the Asia-Pacific region [...]

Novotech Publishes Nasopharyngeal Carcinoma Global Clinical Trial Landscape Report

BOSTON, Sept. 7 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report – “Nasopharyngeal Carcinoma: Global Clinical Trial Landscape”. According to the report, since 2018, the biopharma industry has initiated over 200 global clinical trials for nasopharyngeal carcinoma (NPC), with 60% of these [...]

Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

SINGAPORE, July 13 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities is a finalist in the Asia Pacific Cell & Gene Therapy Awards 2023. The winner will be announced at the 7th Cell & Gene Therapy World Asia in Singapore on 13 September 2023. Novotech is currently the recipient of the Asia Pacific Cell & Gene Therapy [...]

Novotech Presents Technical Session on Clinical Trial Success Factors at BIOPLUS-INTERPHEX KOREA 2023

SEOUL, Korea, July 10 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities will present a technical session at BIOPLUS-INTERPHEX KOREA 2023 for biotechs planning regional or global trials. Novotech’s Vice President, Global Head of Clinical Services Yooni Kim will open the session which will be followed by presentations [...]